Drug Information

Drug General Information
Drug ID
D01EBJ
Former ID
DIB012167
Drug Name
4991W93
Drug Type
Small molecular drug
Indication Migraine [ICD9: 346; ICD10:G43] Discontinued in Phase 2 [546577]
Company
Glaxo Wellcome plc
Formula
C18H23N3O2
Canonical SMILES
c1(c2c([nH]c1)ccc(c2)C[C@@H]1NC(=O)OC1)[C@@H]1C[C@H](C1<br />)N(C)C
CAS Number
CAS 171549-56-7
PubChem Compound ID
9818279
Target and Pathway
Target(s) Sodium channel Target Info Modulator [531151]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and Ankyrins
References
Ref 546577Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009029)
Ref 531151CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 2010 Oct;6(10):573-82.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.